Acute Mixed manic depressive episode

Drugs
Drugs and Targets

Drug	Drug Name	Drug Description
DB00246	Ziprasidone	An atypical antipsychotic used to manage schizophrenia, bipolar mania, and agitation in patients with schizophrenia.

Drug	Drug Name	Target	Type
DB00246	Ziprasidone	Alpha-1A adrenergic receptor	target
DB00246	Ziprasidone	Dopamine D2 receptor	target
DB00246	Ziprasidone	5-hydroxytryptamine receptor 2C	target
DB00246	Ziprasidone	Dopamine D3 receptor	target
DB00246	Ziprasidone	5-hydroxytryptamine receptor 1A	target
DB00246	Ziprasidone	5-hydroxytryptamine receptor 1D	target
DB00246	Ziprasidone	Histamine H1 receptor	target
DB00246	Ziprasidone	5-hydroxytryptamine receptor 2A	target
DB00246	Ziprasidone	Dopamine D4 receptor	target
DB00246	Ziprasidone	5-hydroxytryptamine receptor 7	target
DB00246	Ziprasidone	Cytochrome P450 3A4	enzyme
DB00246	Ziprasidone	Alpha-2A adrenergic receptor	target
DB00246	Ziprasidone	Alpha-1B adrenergic receptor	target
DB00246	Ziprasidone	Alpha-2B adrenergic receptor	target
DB00246	Ziprasidone	Alpha-2C adrenergic receptor	target
DB00246	Ziprasidone	Dopamine D1 receptor	target
DB00246	Ziprasidone	Dopamine D5 receptor	target
DB00246	Ziprasidone	Muscarinic acetylcholine receptor M1	target
DB00246	Ziprasidone	Muscarinic acetylcholine receptor M2	target
DB00246	Ziprasidone	Muscarinic acetylcholine receptor M3	target
DB00246	Ziprasidone	Muscarinic acetylcholine receptor M4	target
DB00246	Ziprasidone	Muscarinic acetylcholine receptor M5	target
DB00246	Ziprasidone	5-hydroxytryptamine receptor 1B	target
DB00246	Ziprasidone	5-hydroxytryptamine receptor 1E	target
DB00246	Ziprasidone	5-hydroxytryptamine receptor 6	target
DB00246	Ziprasidone	Aldehyde oxidase	enzyme
DB00246	Ziprasidone	Serum albumin	carrier
DB00246	Ziprasidone	P-glycoprotein 1	transporter
DB00246	Ziprasidone	Alpha-1-acid glycoprotein 1	carrier
DB00246	Ziprasidone	5-hydroxytryptamine 3 receptor	target
DB00246	Ziprasidone	5-hydroxytryptamine receptor 5A	target

Drug	Drug Name	Phase	Status	Count